{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:06:16Z","timestamp":1789506376865,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Dutch Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019573","name":"Amsterdam University Medical Centers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020252","name":"CRUK Lung Cancer Centre of Excellence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017636","name":"Cancer Center Amsterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xcrm.2026.103006","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:45:19Z","timestamp":1787582719000},"page":"103006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell-free DNA genomic and fragmentomic features for early outcome prediction in large B cell lymphoma"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5473-9415","authenticated-orcid":false,"given":"Steven","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Mapar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ymke","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram","family":"Safrastyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normastuti Adhini","family":"Tantyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Snieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 F.","family":"Do Brito Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Vera","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Dinmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther E.E.","family":"Drees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaretha G.M.","family":"Roemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bauke","family":"Ylstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara P.W.","family":"Klerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Strobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorick","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinske S.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Koene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Pruijt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"de Heer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozemarijn","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz M.","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"de Jongh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Nijland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"van der Poel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens","family":"Nieuwenhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Fijnheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aart","family":"Beeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier","family":"Mous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke K.J.","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost S.P.","family":"Vermaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Michiel","family":"Pegtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine E.D.","family":"Chamuleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7043-0514","authenticated-orcid":false,"given":"Florent","family":"Mouliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103006_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse Large B-Cell Lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2026.103006_bib3","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","article-title":"Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study","volume":"130","author":"Crump","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103006_bib4","first-page":"1896","article-title":"Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma","volume":"28","author":"Moskowitz","year":"2010","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.xcrm.2026.103006_bib5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa1301077","article-title":"Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin\u2019s Lymphoma","volume":"369","author":"Stiff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib6","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1470-2045(17)30444-8","article-title":"Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study","volume":"18","author":"Chiappella","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.103006_bib7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/blood-2017-02-766691","article-title":"FDG-PET\u2013driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study","volume":"130","author":"Casasnovas","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103006_bib8","first-page":"1285","article-title":"Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non\u2013Germinal Center B-Cell Diffuse Large B-Cell Lymphoma","volume":"37","author":"Younes","year":"2019","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.xcrm.2026.103006_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30935-5","article-title":"Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial","volume":"20","author":"Davies","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.103006_bib10","first-page":"1317","article-title":"ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma","volume":"39","author":"Nowakowski","year":"2021","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.xcrm.2026.103006_bib11","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa2206913","article-title":"Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma","volume":"387","author":"Dickinson","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41591-022-01731-4","article-title":"Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial","volume":"28","author":"Neelapu","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.molmed.2024.04.005","article-title":"Turning the tide in aggressive lymphoma: liquid biopsy for risk-adapted treatment strategies","volume":"30","author":"Wang","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib15","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","article-title":"Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer","volume":"386","author":"Tie","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41576-026-00974-y","article-title":"Advancing the applications of liquid biopsies in oncology","volume":"27","author":"Valpione","year":"2026","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2026.103006_bib17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s41587-021-00981-w","article-title":"Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA","volume":"39","author":"Kurtz","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103006_bib18","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1200\/JCO-25-01534","article-title":"Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma","volume":"43","author":"Roschewski","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103006_bib19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/JCO-25-01712","article-title":"Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma","volume":"44","author":"Wang","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103006_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1200\/JCO-25-01587","article-title":"Phased Variant\u2013Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study","volume":"44","author":"Krupka","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103006_bib21","first-page":"2845","article-title":"Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma","volume":"36","author":"Kurtz","year":"2018","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.xcrm.2026.103006_bib22","doi-asserted-by":"crossref","first-page":"e152.70093","DOI":"10.1002\/hon.70093_152","article-title":"152 | Glofitamab+R-CHOP in Patients with Previously Untreated Large B-Cell Lymphoma Defined as High Risk by Circulating Tumor DNA (ctDNA) Dynamics: Primary Results","volume":"43","author":"Nijland","year":"2025","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2026.103006_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/blood-2025-474","article-title":"Longitudinal circulating tumor DNA dynamics during & after first-line therapy in a national cohort of large B-cell lymphomas","volume":"146","author":"Wang","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103006_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ccell.2019.09.003","article-title":"Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA","volume":"36","author":"van der Pol","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103006_bib26","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103006_bib27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41591-020-0915-3","article-title":"Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring","volume":"26","author":"Zviran","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib28","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1038\/s41467-021-23445-w","article-title":"Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden","volume":"12","author":"Peneder","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103006_bib29","first-page":"ii6","article-title":"A hitchhiker\u2019s guide to cell-free DNA biology","volume":"4","author":"Mouliere","year":"2022","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.xcrm.2026.103006_bib30","article-title":"Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis","volume":"5","author":"Moldovan","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103006_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66503-3","article-title":"Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell types","volume":"16","author":"Olsen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103006_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib34","article-title":"FinaleToolkit: accelerating cell-free DNA fragmentation analysis with a high-speed computational toolkit","volume":"236","author":"Li","year":"2025","journal-title":"Bioinform. Adv."},{"key":"10.1016\/j.xcrm.2026.103006_bib35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccell.2016.04.011","article-title":"Coordinated Tumor Suppression by Chromosome 8p","volume":"29","author":"Tschaharganeh","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103006_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz8084","article-title":"ctDNA monitoring using patient-specific sequencing and integration of variant reads","volume":"12","author":"Wan","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib38","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1016\/j.cell.2025.10.020","article-title":"Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction","volume":"188","author":"Black","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103006_bib39","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS7095","article-title":"Sequencing-guided chemotherapy optimization using real-time evaluation in newly diagnosed DLBCL with circulating tumor DNA: SHORTEN-ctDNA (NCT06693830)","volume":"43","author":"Cherng","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103006_bib40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1470-2045(18)30192-X","article-title":"Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial","volume":"19","author":"Saussele","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.103006_bib41","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1158\/1078-0432.CCR-21-0110","article-title":"Tumor-Na\u00efve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma","volume":"27","author":"Burgener","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103006_bib42","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s44321-026-00396-7","article-title":"Cell-free DNA methylome and fragmentome analysis for relapse monitoring of Ewing sarcoma","volume":"18","author":"Richardson","year":"2026","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib43","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2009-10-247122","article-title":"Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study","volume":"116","author":"Jardin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103006_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/ejh.12171","article-title":"Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome","volume":"91","author":"Fiskvik","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.xcrm.2026.103006_bib45","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2967\/jnumed.124.267789","article-title":"International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline18 F-FDG PET\/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation","volume":"65","author":"Boellaard","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib46","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3324\/haematol.2021.278663","article-title":"Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study","volume":"107","author":"Kostakoglu","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2026.103006_bib47","first-page":"3055","article-title":"Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma","volume":"141","author":"Eertink","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103006_bib48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.medj.2024.03.007","article-title":"Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas","volume":"5","author":"Arffman","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.xcrm.2026.103006_bib49","first-page":"2605","article-title":"Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma","volume":"39","author":"Alig","year":"2021","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.xcrm.2026.103006_bib50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1078-0432.CCR-20-2558","article-title":"Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study","volume":"27","author":"Rivas-Delgado","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103006_bib51","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood.2021012852","article-title":"Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma","volume":"139","author":"Meriranta","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103006_bib52","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","article-title":"TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands","volume":"105","author":"Van Der Meij","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xcrm.2026.103006_bib53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-genom-083118-015053","article-title":"The Emergence and Global Spread of Noninvasive Prenatal Testing","volume":"22","author":"Ravitsky","year":"2021","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.xcrm.2026.103006_bib54","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.21037\/atm-20-6833","article-title":"Immune checkpoint inhibitors in lymphoma: challenges and opportunities","volume":"9","author":"Hatic","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103006_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2426890122","article-title":"Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases","volume":"122","author":"Curtis","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103006_bib56","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41418-024-01272-y","article-title":"Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck","volume":"31","author":"Sanz-Garcia","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2026.103006_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads5002","article-title":"Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer","volume":"11","author":"Hruban","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.103006_bib58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-025-03348-0","article-title":"Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer","volume":"44","author":"Janke","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103006_bib59","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/s41587-022-01652-0","article-title":"Simultaneous sequencing of genetic and epigenetic bases in DNA","volume":"41","author":"F\u00fcllgrabe","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103006_bib60","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows\u2013Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.103006_bib61","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"2013","journal-title":"arXiv"},{"key":"10.1016\/j.xcrm.2026.103006_bib62","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.xcrm.2026.103006_bib63","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","article-title":"Sambamba: fast processing of NGS alignment formats","volume":"31","author":"Tarasov","year":"2015","journal-title":"Bioinformatics"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:15:02Z","timestamp":1789503302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666379126004234"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103006","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-free DNA genomic and fragmentomic features for early outcome prediction in large B cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103006"}}